Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb:31 Suppl 24:8-10.
doi: 10.1111/pai.13163.

Immunodeficiency and disorders of immune dysregulation

Ottavia Maria Delmonte  1
Affiliations

Immunodeficiency and disorders of immune dysregulation

Ottavia Maria Delmonte. Pediatr Allergy Immunol. 2020 Feb.

Abstract

The spectrum of clinical features associated with primary immune deficiency disorders (PIDs) has broadened due to the recent identification of many novel causative genes. Patients present with increased susceptibility to infections in addition to significant immune dysregulation, often leading to multiple autoimmunity, lymphoproliferation, and malignancy. Immunosuppressive treatment is often required but has to be weighed against augmented infectious risk. Recently, the improved molecular understanding of the mechanisms underlying many loss-of-function (LOF) and gain-of-function (GOF) genetic defects leading to PIDs has set the ground for the development of mechanism-based therapeutic strategies that target a specific cell function. This article describes the clinical and laboratory features of selected recently described PIDs associated with immune dysregulation and novel precision medicine strategies aimed to control the disease burden in affected patients.

Keywords: immune dysregulation; precision medicine; primary immunodeficiency diseases.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Update in Primary Immunodeficiencies.
    Leonardi L, Rivalta B, Cancrini C, Chiappini E, Cravidi C, Caffarelli C, Manti S, Calvani M, Martelli A, Miraglia Del Giudice M, Duse M, Marseglia GL, Cardinale F. Leonardi L, et al. Acta Biomed. 2020 Sep 15;91(11-S):e2020010. doi: 10.23750/abm.v91i11-S.10314. Acta Biomed. 2020. PMID: 33004780 Free PMC article. Review.

References

REFERENCES

    1. Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N, Members of the CEREDIH French PID Study Group. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017;140:1388-1393.
    1. Hadjadj J, Aladjidi N, Fernandes H,, et al. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. 2019;134:9-21.
    1. Schuetz C, Hoenig M, Moshous D,, et al. Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation. Blood Adv. 2018;2:2550-2553.
    1. Kuehn HS, Ouyang W, Lo B,, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345:1623-1627.
    1. Schwab C, Gabrysch A, Olbrich P,, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol. 2018;142:1932-1946.

Publication types

MeSH terms

LinkOut - more resources